Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases

Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases

Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening cytokine storm syndrome. There are no definitive guidelines for the management of secondary HLH (sHLH). A recent report by a National Health Service (NHS) clinical panel has recommended anakinra as a treatment option. We aimed to analyse...

Full description

Bibliographic Details
Main Authors: Clara Baverez, Maximilien Grall, Mathieu Gerfaud-Valentin, Sarah De Gail, Alexandre Belot, Thomas Perpoint, Emmanuelle Weber, Quitterie Reynaud, Pascal Sève, Yvan Jamilloux
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Journal of Clinical Medicine
Subjects:
anakinra
interleukin-1
hemophagocytic lymphohistiocytosis
adult onset Still’s disease
immunotherapy
cytokines
Online Access:https://www.mdpi.com/2077-0383/11/19/5799

Internet

https://www.mdpi.com/2077-0383/11/19/5799

Similar Items